Stock price
Market cap
At each fiscal year end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jul 31, 2017 | $35.0B |
| FY2018, ended Jul 31, 2018 | $52.8B |
| FY2019, ended Jul 31, 2019 | $72.1B |
| FY2020, ended Jul 31, 2020 | $80.2B |
| FY2021, ended Jul 31, 2021 | $145B |
| FY2022, ended Jul 31, 2022 | $129B |
| FY2023, ended Jul 31, 2023 | $143B |
| FY2024, ended Jul 31, 2024 | $181B |
| FY2025, ended Jul 31, 2025 | $219B |
| FY2026, ended Jul 31, 2026 | $84.5B |
Revenue
By fiscal year
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jul 31, 2017 | $5.20B |
| FY2018, ended Jul 31, 2018 | $6.03B |
| FY2019, ended Jul 31, 2019 | $6.78B |
| FY2020, ended Jul 31, 2020 | $7.68B |
| FY2021, ended Jul 31, 2021 | $9.63B |
| FY2022, ended Jul 31, 2022 | $12.7B |
| FY2023, ended Jul 31, 2023 | $14.4B |
| FY2024, ended Jul 31, 2024 | $16.3B |
| FY2025, ended Jul 31, 2025 | $18.8B |
| FY2026, ended Jul 31, 2026 | $21.4B |
Net income and free cash flow
By fiscal year. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jul 31, 2017 | $985M | $1.50B |
| FY2018, ended Jul 31, 2018 | $1.33B | $2.07B |
| FY2019, ended Jul 31, 2019 | $1.56B | $2.25B |
| FY2020, ended Jul 31, 2020 | $1.83B | $2.35B |
| FY2021, ended Jul 31, 2021 | $2.06B | $3.20B |
| FY2022, ended Jul 31, 2022 | $2.07B | $3.73B |
| FY2023, ended Jul 31, 2023 | $2.38B | $4.84B |
| FY2024, ended Jul 31, 2024 | $2.96B | $4.69B |
| FY2025, ended Jul 31, 2025 | $3.87B | $6.12B |
| FY2026, ended Jul 31, 2026 | $4.57B | $8.66B |
Cash and cash equivalents
At each fiscal year end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jul 31, 2017 | $529M |
| FY2018, ended Jul 31, 2018 | $1.46B |
| FY2019, ended Jul 31, 2019 | $2.12B |
| FY2020, ended Jul 31, 2020 | $6.44B |
| FY2021, ended Jul 31, 2021 | $2.56B |
| FY2022, ended Jul 31, 2022 | $2.80B |
| FY2023, ended Jul 31, 2023 | $2.85B |
| FY2024, ended Jul 31, 2024 | $3.61B |
| FY2025, ended Jul 31, 2025 | $2.88B |
| FY2026, ended Jul 31, 2026 | $4.71B |
Total debt
At each fiscal year end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jul 31, 2017 | $438M |
| FY2018, ended Jul 31, 2018 | $388M |
| FY2019, ended Jul 31, 2019 | $386M |
| FY2020, ended Jul 31, 2020 | $2.03B |
| FY2021, ended Jul 31, 2021 | $2.03B |
| FY2022, ended Jul 31, 2022 | $6.91B |
| FY2023, ended Jul 31, 2023 | $6.12B |
| FY2024, ended Jul 31, 2024 | $6.04B |
| FY2025, ended Jul 31, 2025 | $5.97B |
| FY2026, ended Jul 31, 2026 | $7.67B |
Shares outstanding
At each fiscal year end, adjusted for splits. Up 4.8% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jul 31, 2017 | 255M |
| FY2018, ended Jul 31, 2018 | 259M |
| FY2019, ended Jul 31, 2019 | 260M |
| FY2020, ended Jul 31, 2020 | 262M |
| FY2021, ended Jul 31, 2021 | 273M |
| FY2022, ended Jul 31, 2022 | 282M |
| FY2023, ended Jul 31, 2023 | 280M |
| FY2024, ended Jul 31, 2024 | 280M |
| FY2025, ended Jul 31, 2025 | 279M |
| FY2026, ended Jul 31, 2026 | 267M |
Buybacks and new shares
By fiscal year, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2017, ended Jul 31, 2017 | $839M | $326M | — |
| FY2018, ended Jul 31, 2018 | $272M | $382M | — |
| FY2019, ended Jul 31, 2019 | $556M | $401M | $0 |
| FY2020, ended Jul 31, 2020 | $323M | $435M | $0 |
| FY2021, ended Jul 31, 2021 | $1.00B | $753M | $3.80B |
| FY2022, ended Jul 31, 2022 | $1.86B | $1.31B | $6.32B |
| FY2023, ended Jul 31, 2023 | $1.97B | $1.71B | $0 |
| FY2024, ended Jul 31, 2024 | $1.99B | $1.94B | $0 |
| FY2025, ended Jul 31, 2025 | $2.77B | $1.97B | — |
| FY2026, ended Jul 31, 2026 | $5.41B | $2.06B | — |
Valuation
At current price- Market Cap
- $87.8B
- P/E
- 19.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.1×
- Price / Book
- 4.6×
- EV / EBITDA
- 13.8×
Growth
Trailing 12 months- Revenue (TTM)
- $21.4B
- Revenue Growth YoY
- 13.9%
- Revenue CAGR 3Y
- 14.3%
- Revenue CAGR 5Y
- 17.4%
- EPS Growth YoY
- 20.4%
- Net Income Growth YoY
- 18.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 27.4%
- Net Margin
- 21.3%
- FCF Margin
- 40.4%
- Return on Equity
- 23.6%
Earnings
Trailing 12 months- Net Income
- $4.57B
- EPS (diluted)
- $16.46
- EBITDA
- $6.56B
- Operating Income
- $5.88B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $4.71B
- Total Debt
- $7.67B
- Net Debt
- $2.96B
- Total Assets
- $36.8B
- Total Liabilities
- $17.8B
- Shareholders' Equity
- $19.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $8.84B
- Capital Expenditure
- $175M
- Free Cash Flow
- $8.66B
Dividends and risk
Last 12 months- Dividend Yield
- 1.5%
- Dividend / Share
- $4.98
- Beta (5Y)
- 1.01
Every ratio is calculated from the company’s reported figures.